As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.
Tag: Rutgers University
What is Ovarian Cancer?
Ovarian Cancer is expected to impact 22,000 U.S. women this year. Rutgers Cancer Institute of New Jersey Gynecologic Oncologist Dr. Mihae Song shares some facts during this Ovarian Cancer Awareness Month.
What is Thyroid Cancer?
September is Thyroid Cancer Awareness Month and Dr. Amanda Laird, Chief of Endocrine Surgery at Rutgers Cancer Institute of New Jersey shares information on types of thyroid cancer, how it is diagnosed and treatment options.
Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients
In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.
Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients
In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.
Leukemia: Not Just One Disease
An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.
$1.5M Awarded from ORIEN New Oncologic Visionary Awards Program Supports Research by Rutgers Cancer Institute Investigators
A pair of Rutgers Cancer Institute of New Jersey physician-scientists are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program.
RWJBarnabas Health and Rutgers Cancer Institute Announce New $750 Million, Free-Standing Cancer Pavilion in New Brunswick
NEW BRUNSWICK, N.J., June 19, 2019 – RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, in partnership with New Brunswick Development Corporation have announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. The initial estimated…